INDEC Biosystem Inc.
Targeson Inc.
ChinaBio LLC
U.S. National Cancer Institute
China SFDA
Preclinical Study
Ex vivo Analysis

In preclinical study, histopathology analysis for the samples collected from in vivo study can provide valuable information regarding activity, mechanism, safety of the test drug and verification of the presence of drug targets or biomarkers.  We offer a complete range of histopathology services in support of customer¡¯s preclinical pharmacology study including:

•Formalin-fixed tissue sample for standard H&E staining for primary tumor, metastasis and necrosis assessment.
•Frozen tissue sample for immunohistochemistry for angiogenesis, apoptosis and tumor surface markers.
•Real-time PCR for quantitative detection of gene expression in the test sample to determine whether alterations in gene expression are associated with drug efficacy.